JP2006528627A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006528627A5 JP2006528627A5 JP2006520939A JP2006520939A JP2006528627A5 JP 2006528627 A5 JP2006528627 A5 JP 2006528627A5 JP 2006520939 A JP2006520939 A JP 2006520939A JP 2006520939 A JP2006520939 A JP 2006520939A JP 2006528627 A5 JP2006528627 A5 JP 2006528627A5
- Authority
- JP
- Japan
- Prior art keywords
- natural killer
- killer cells
- alloreactive
- therapeutic antibody
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000822 natural killer cell Anatomy 0.000 claims 34
- 230000001225 therapeutic effect Effects 0.000 claims 23
- 239000000203 mixture Substances 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 6
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims 4
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims 4
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 229960004641 rituximab Drugs 0.000 claims 3
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48950903P | 2003-07-24 | 2003-07-24 | |
| PCT/IB2004/002637 WO2005009466A1 (en) | 2003-07-24 | 2004-07-23 | Methods and compositions for increasing the efficiency of therapeutic antibodies using alloreactive natural killer cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006528627A JP2006528627A (ja) | 2006-12-21 |
| JP2006528627A5 true JP2006528627A5 (https=) | 2007-07-26 |
Family
ID=34102891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006520939A Pending JP2006528627A (ja) | 2003-07-24 | 2004-07-23 | アロ反応性ナチュラルキラー細胞を使用する治療用抗体の有効性を増加するための方法および組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20060240005A1 (https=) |
| EP (1) | EP1648508A1 (https=) |
| JP (1) | JP2006528627A (https=) |
| WO (1) | WO2005009466A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2069478A2 (en) * | 2006-08-07 | 2009-06-17 | PDL BioPharma, Inc. | Use of allogeneic effector cells and anti-cs1 antibodies for selective killing of multiple myeloma cells |
| GB0707208D0 (en) * | 2007-04-13 | 2007-05-23 | Istituto Superiore Di Sanito | Novel disease treatments |
| EP2111869A1 (en) | 2008-04-23 | 2009-10-28 | Stichting Sanquin Bloedvoorziening | Compositions and methods to enhance the immune system |
| WO2011053322A1 (en) * | 2009-10-30 | 2011-05-05 | University Of Arkansas For Medical Science | Use of autologous effector cells and antibodies for treatment of multiple myeloma |
| KR101940430B1 (ko) | 2014-08-07 | 2019-01-18 | 가꼬우호우징 효고 이카다이가쿠 | Il-18과 분자 표적 항체를 병용하는 암 치료약 |
| WO2016022589A2 (en) | 2014-08-08 | 2016-02-11 | The Regents Of The University Of California | Methods for treating multiple myeloma |
| WO2017042393A1 (en) * | 2015-09-11 | 2017-03-16 | Emercell Sas | Pooled nk cells from umbilical cord blood associated with antibodies and their uses for the treatment of disease |
| WO2018083080A2 (en) | 2016-11-04 | 2018-05-11 | Innate Pharma | Nkp46 ligand |
| AU2018265534A1 (en) * | 2017-05-11 | 2019-10-31 | Nantkwest, Inc. | Anti-EGFR/high affinity NK-cells compositions and methods for chordoma treatment |
| JP6647240B2 (ja) | 2017-05-12 | 2020-02-14 | 米満 吉和 | 高活性ｎｋ細胞、およびその利用 |
| US11393251B2 (en) | 2018-02-09 | 2022-07-19 | Pupil Labs Gmbh | Devices, systems and methods for predicting gaze-related parameters |
| EP3750028B1 (en) | 2018-02-09 | 2022-10-19 | Pupil Labs GmbH | Devices, systems and methods for predicting gaze-related parameters |
| EP3750029A1 (en) | 2018-02-09 | 2020-12-16 | Pupil Labs GmbH | Devices, systems and methods for predicting gaze-related parameters using a neural network |
| EP3912013A1 (en) | 2019-01-16 | 2021-11-24 | Pupil Labs GmbH | Methods for generating calibration data for head-wearable devices and eye tracking system |
| JP6697611B2 (ja) * | 2019-05-20 | 2020-05-20 | 米満 吉和 | 高活性ｎｋ細胞、およびその利用 |
| US11676422B2 (en) | 2019-06-05 | 2023-06-13 | Pupil Labs Gmbh | Devices, systems and methods for predicting gaze-related parameters |
| EP3987380B1 (en) | 2019-06-18 | 2024-10-16 | Pupil Labs GmbH | Systems and methods for determining one or more parameters of a user's eye |
| EP3973346B1 (en) | 2020-02-19 | 2024-12-25 | Pupil Labs GmbH | Eye tracking module and head-wearable device |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1974747E (pt) * | 1998-08-11 | 2012-09-05 | Biogen Idec Inc | Terapias de combinação para linfomas de células b compreendendo a administração de anticorpo anti-cd20 |
| US6979546B2 (en) * | 1999-11-15 | 2005-12-27 | Universita Di Genova | Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same |
| HRP20170342T1 (hr) * | 2003-07-24 | 2017-05-19 | Innate Pharma S.A. | Metode i sastavi za povećanje učinkovitosti terapijskih protutijela koristeći tvari koje potenciraju nk stanice |
-
2004
- 2004-07-23 US US10/565,761 patent/US20060240005A1/en not_active Abandoned
- 2004-07-23 WO PCT/IB2004/002637 patent/WO2005009466A1/en not_active Ceased
- 2004-07-23 EP EP04769123A patent/EP1648508A1/en not_active Withdrawn
- 2004-07-23 JP JP2006520939A patent/JP2006528627A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006528627A5 (https=) | ||
| CN113597328B (zh) | 用于治疗过敏症的il-4/il-13途径抑制剂和浆细胞消融的组合 | |
| TWI697334B (zh) | 藉由投與ｉｌ-４ｒ抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法 | |
| JP2009539841A5 (https=) | ||
| CN109789196B (zh) | 用于通过施用il-4r拮抗剂来预防或治疗变态反应的方法 | |
| JP2009114201A5 (https=) | ||
| JP2012519712A5 (https=) | ||
| JP2009518441A5 (https=) | ||
| JP2019527678A5 (https=) | ||
| JP2014533279A5 (https=) | ||
| JP2016509582A5 (https=) | ||
| JP2009519257A5 (https=) | ||
| RU2010112940A (ru) | Комбинированная терапия антителами анти-cd20 типа i и типа ii | |
| JP2006506333A5 (https=) | ||
| JP2020510039A5 (https=) | ||
| JP2009533367A5 (https=) | ||
| JP2019518742A5 (https=) | ||
| RU2011104955A (ru) | Композиции антител | |
| JP2006528626A5 (https=) | ||
| US20150023972A1 (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
| JP2015534579A5 (https=) | ||
| JP2013518912A5 (https=) | ||
| JP2015502138A5 (https=) | ||
| ES2860480T3 (es) | Anticuerpos neutralizantes de GM-CSF para su uso en el tratamiento de la artritis reumatoide o como analgésicos | |
| JP2013537539A5 (https=) |